Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

By continuing you agree to the terms and privacy policy.

Welcome — one more step

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Ask Duki without the monthly limit — answers from the coverage, with sources
  • Save articles, synced between the web and the app
  • Every Not Everywhere story, no daily limit
  • How each newsroom worded the same event
  • Filing timeline and coverage breakdown
  • The whole archive, searchable
  • Unlimited newsroom, topic and people follows
  • The daily brief by email, in English or Hebrew

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Download on theApp StoreGet it onGoogle Play

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

מסוף חי
טכנולוגיה · סיקור מלא

Israeli AI Founder Maor Shlomo Launches Private Cancer Research Investment Fund

איך 2 חדרי חדשות ישראליים סיפרו את הסיפור הזה, זה לצד זה.

Center 1Unrated 1

מאת ynet

דווח לראשונה בCalcalist · יולי 30, 2026

מה קרה

Maor Shlomo, founder of Israeli AI startup Base44, has launched a private investment fund focused on cancer research and innovative therapies, motivated by his mother's recent death from cancer. The fund has invested in seven companies over four months, aiming to accelerate drug development and testing through AI technologies. Shlomo calls for additional investors to join and plans to share further details soon.

  • 01Maor Shlomo founded a private cancer research investment fund after losing his mother to cancer.
  • 02The fund has invested in seven companies in four months, focusing on breakthrough therapies.
  • 03Shlomo emphasizes AI's role in speeding drug design and identifies manufacturing and testing as new bottlenecks.
  • 04He highlights companies like Starget Pharma, CuResponse, Cellint, and Baccine in his portfolio.
  • 05Shlomo continues leading Base44 while supporting portfolio firms with AI expertise.
  • 06He invites others to invest or assist and will announce more fund details later.

התקציר תורגם וסוכם מהמקורות למטה על ידי baba. לקריאה המלאה פתחו כל מקור.

In this story
People
OrganizationsBase44, Wix, Starget Pharma, CuResponse, Cellint, Baccine, Even One Ventures, GitLab
PlacesIsrael

סיקור מלא · 2 מקורות

אותו אירוע, כפי שכל חדר חדשות דיווח עליו בנפרד. פתחו כמה כדי להשוות במה כל אחד מדגיש ומה הוא משמיט.

סיפורים קשורים

Israeli AI Entrepreneur Maor Shlomo Sells Solo Startup for $80 Million After Months of Sleepless Workאוג׳ 16, 2026Israeli Innovation Authority Leads $70 Million AI Consortium for Personalized Medicineיולי 12, 2026Merav Bahat Launches New Founders-First AI Fund With Assaf Rappaportיוני 24, 2026Israeli Startup QuantHealth Raises $45 Million to Revolutionize Drug Development with AIאוג׳ 5, 2026Former Israeli Military Officer Leads AI-Driven Biotech Startup Incubator with Nine Ventures Foundedיולי 2, 2026שליש מהחברות, 89% מהכסף: ה-AI משתלט על גיוסי ההייטק הישראלילפני 15 שעות